Stay updated on Enfortumab Vedotin in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enfortumab Vedotin in Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2; no substantive content changes to the study details are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T15:43:35.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a PubMed auto-fill disclaimer indicating that publications are automatically filled from PubMed and may not pertain to the study. Updated the revision label to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T11:16:35.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The funding-status notice banner was removed from the page. The study details and navigation remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-17T06:11:56.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    New date labels such as 'Last Update Posted (Estimated)' and recent dates (e.g., 2025-11-03, 2025-10-31) were added to the Study Details page, reflecting update history and not altering study data or eligibility; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-10T02:08:37.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added publication reference: Muro K et al. Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers, ESMO Open. 2025;10(11):105806 (doi:10.1016/j.esmoop.2025.105806). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T00:50:08.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    - Added a government funding operating-status notice and a new version tag v3.2.0. - Removed a specific resource reference: Genetic and Rare Diseases Information Center resources: Carcinoma of esophagus (with revision v3.1.0). If the resource was not core, this removal is minor; the new status notice is the primary change.
    Difference
    1%
    Check dated 2025-10-05T06:40:31.000Z thumbnail image

Stay in the know with updates to Enfortumab Vedotin in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.